PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
https://doi.org/10.21292/2078-5658-2017-14-2-72-79
Abstract
The frequency of sudden cardiac death remains still high, globally every year 3 mln. people suddenly die. During last thirty years it has been possible to prevent sudden cardiac death by using implantable cardioverter-defibrillators. For all this time the number of large clinical trials has been conducted confirming the improved survival when using implantable cardioverter-defibrillators. The last edition of Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death was presented by European Society of Cardiology in 2015. However there are a lot of unsolved problems first of all related to indications for implantation of cardioverter-defibrillators. This review analyzes the existing evidences and depicts the current use of implantable cardioverter-defibrillators in the clinical practice.
About the Author
N. V. Melnik
I. M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Assistant of Faculty Therapy Department no. 1
Russian Federation
Assistant of Faculty Therapy Department no. 1
References
1. Bansch D., Antz M., Boczor S., Volkmer M., Tebbenjohanns J., Seidl K. et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation, 2002, vol. 10, pp. 1453-1458.
2. Bardy G.H., Lee K.L., Mark D.B., Poole J.E. Long-term Follow-up in the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT). Heart Rhythm, 2012, vol. 9, pp. 1579.
3. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med., 2005, vol. 352, no. 3, pp. 225-237.
4. Bigger J.T.Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N. Engl. J. Med., 1997, vol. 337, no. 22, pp. 1569-1575.
5. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N. Engl. J. Med., 1999, vol. 341, pp.1882–1890.
6. Connolly S.J., Gent M., Roberts R.S., Dorian P., Roy D., Sheldon R.S. et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 2000, vol. 101, pp. 1297-1302.
7. Connolly S.J., Hallstrom A.P., Cappato R., Schron E.B., Kuck K.H., Zipes D.P. et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmicsvs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur. Heart J., 2000, vol. 21, pp. 2071-2078.
8. Deo R., Albert C.M. Epidemiology and genetics of sudden cardiac death. Circulation, 2012, vol. 125, no. 4, pp. 620-637.
9. Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization, Geneva 2011.Available at: http://www.world-heart-federation. org/fileadmin/user_upload/images/CVD_Health/Global_CVD_Atlas.pdf
10. Goldenberg I., Gillespie J., Moss A.J., Hall W.J., Klein H., McNitt S. et al. Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation, 2010, vol. 122, no. 13, pp. 1265-1271.
11. Greenspon A.J., Patel J.D., Lau E., Ochoa J.A., Frisch D.R., Ho R.T. et al. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008 Infection Trends for Pacemakers and ICDs. JACC, 2011, vol. 58, no. 10, pp. 1001-1006.
12. Hohnloser S.H., Kuck K.H., Dorian P., Roberts R.S., Hampton J.R., Hatala R. et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med., 2004, vol. 351, pp. 2481-2488.
13. Kadish A., Dyer A., Daubert J.P., Quigg R., Estes N.A., Anderson K.P. et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med., 2004, vol. 350, pp. 2151-2158.
14. Kuck K.H., Cappato R., Siebels J., Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation, 2000, vol. 102, pp. 748-754.
15. Merchant F.M., Jones P., Wehrenberg S., Lloyd M.S., Saxon L. A.http://jaha. ahajournals.org/content/3/6/e001289.full - aff-3 Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J. Am. Heart Assoc., 2014, vol. 3. Available at:https://www.ncbi.nlm.nih. gov/pmc/articles/PMC4338723/
16. Moss A.J. MADIT-I and MADIT-II. Cardiovasc. Electrophysiol., 2003, vol. 14 (9 suppl.), pp. S96–S98.
17. Moss A.J., Fadl Y., Zareba W., Cannom D.S., Hall W.J. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am. J. Cardiol., 2001, vol. 88, pp. 516-520.
18. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S. L., Klein H. et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N. Engl. J. Med., 1996, vol. 335, pp. 1933-1940.
19. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S. et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med., 2002, vol. 346, no. 12, pp. 877-883.
20. Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation, 1992, vol. 85, pp. 10-12.
21. Myerburg R.J., Luceri R.M., Thurer R., Cooper D.K., Zaman L., Interian A. et al. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. JACC, 1989, vol. 14, no. 2, pp. 508-514.
22. Nichol G., Thomas E., Callaway C.W., Hedges J., Powell J.L., Aufderheide T.P. et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA, 2008, vol. 300, pp. 1423-1431.
23. Priori S.G., Blomström-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Eur. Heart J., 2015, vol. 36, no. 41, pp. 2793-2867.
24. Saxon L.A., Hayes D.L., Gilliam F.R., Heidenreich P.A., Day J., Seth M. et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation, 2010, vol. 122, no. 23, pp. 2359-2367.
25. Stein K.M., Mittal S., Gilliam F.R., Gilligan D.M., Zhong Q., Kraus S.M. et al. Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace, 2009, vol. 11, no. 6, pp. 734-440.
26. Steinbeck G., Andresen D., Seidl K., Brachmann J., Hoffmann E., Wojciechowski D. et al. Defibrillator implantation early after myocardial infarction. N. Engl. J. Med., 2009, vol. 361, pp. 1427-1436.
27. Strickberger S.A., Hummel J.D., Bartlett T.G., Frumin H.I., Schuger C.D., Beau S.L. et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia–AMIOVIRT. J. Am. Coll. Cardiol., 2003, vol. 41, pp. 1707-1712.
28. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med., 1997, vol. 337, pp. 1576-1583. Available at:http://www.nejm. org/doi/pdf/10.1056/NEJM199711273372202
29. Zheng Z.J., Croft J., Giles W., Mensah G. Clinical investigation and reports sudden cardiac death in the United States, 1989 to 1998. Circulation, 2001, vol. 104, pp. 2158-2163.
Review
For citations:
Melnik N.V. PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015). Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2017;14(2):72-79. (In Russ.) https://doi.org/10.21292/2078-5658-2017-14-2-72-79
Email this article 